News

Rapid Micro Biosystems announces the commercial availability of The Growth Direct™ System for Environmental Monitoring and Bioburden Applications

Rapid Micro Biosystems Bedford, MA (June 9, 2014) – Rapid Micro Biosystems, the provider of automated, rapid, non-destructive detection and enumeration technologies in microbiology, today announced the launch of the next generation of Growth Direct™ System and accompanying applications. The Growth Direct™ System is designed to automate the incubation, detection, enumeration and reporting steps for environmental monitoring and bioburden applications in pharmaceutical quality control laboratories. The technology is based on the detection of the natural auto-fluorescence of microorganisms; requiring no…

Repligen Acquires Bioprocessing Business of Refine Technology

Repligen Corporation WALTHAM, Mass., – Repligen Corporation (Nasdaq:RGEN) announced today that it has acquired the business of Refine Technology (“Refine”), including Refine’s Alternating Tangential Flow (“ATF”) System, a market-leading device used to significantly increase product yield during the fermentation step of the biologic drug manufacturing process. The acquisition strengthens Repligen’s bioprocessing business by adding a profitable and highly complementary product line while expanding the Company’s direct sales presence worldwide. Repligen has entered into a definitive agreement effective June 2, 2014…

Sartorius Stedim Biotech launches new single-use bag family Flexsafe

Sartorius Stedim Biotech Goettingen, Germany | Aubagne, France – Sartorius Stedim Biotech, a leading global supplier of the biopharmaceutical industry, is introducing a brand-new, scalable range of single-use bags. Its completely new developed product family Flexsafe enables the implementation of single-use bioprocessing throughout all steps of drug manufacture, from process development to production, in upstream and downstream – all using just the one innovative polyethylene film. The innovative concept of the Flexsafe family addresses key industry requirements for future-proof single-use…

Natrix Separations Names Peter Tunon Vice President of Sales and Marketing

Natrix Separations Burlington, Ontario, May 22, 2014 — Natrix Separations, Inc., a maker of innovative single-use chromatography products for the biopharmaceutical industry, announced today that Peter Tunon has joined the company as Vice President of Sales & Marketing. In this role, Mr. Tunon will lead all commercial activities for Natrix, including marketing, product management, channel strategy, sales support for channel partners, and business development. A native of Uppsala, Sweden, Mr. Tunon brings over 25 years of professional experience in general…

EMD Millipore Expands Provantage® Upstream Bioproduction Services to the North American Market

EMD Millipore May 5, 2014, Billerica, MA — EMD Millipore, the life science division of Merck KGaA of Darmstadt, Germany, today announces the expansion of its upstream services into North America as part of its Provantage® Biodevelopment and Clinical Supply offering. The company’s Massachusetts facilities will now offer upstream capabilities including media and feed screening, small-scale material production, and optimization of conditions for scale-up and technology transfer. This expansion allows EMD Millipore’s North American customers to access the same services…

Lonza and AMYRA Sign Comprehensive Development and Manufacturing Services Agreement for Enzyme-Based Treatment of Celiac Disease

Lonza • AMYRA Biotech AG to develop a rational oral treatment for celiac disease using a cocktail of two proprietary enzymes • Contract covers the process development and production of AMYRA’s two enzymes for the treatment of celiac disease • Lonza will develop and manufacture AMYRA’s enzymes in their Kourim, Czech Republic facility • Included in the contract is an XS™ Commercial License with access to Lonza’s XS™ Microbial Expression Technology Platform Basel and Zug, Switzerland, 10 April 2014 –…

EMD Millipore Introduces Incoming CEO and President

EMD Millipore Billerica, MA—April 9, 2013—EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany, announces the appointment of Udit Batra, Ph.D. as its incoming President and CEO, responsible for the organization’s strategic direction to drive growth and product innovation as well as oversight of the worldwide operations. Dr. Batra will assume leadership effective May 15, 2014 and be based at the company’s U.S. headquarters in Massachusetts. “As a global leader in the Life Sciences industry, I am…

Siddharth Advant Joins Kemwell as President, Biopharmaceutical Services

Kemwell Bangalore, India – Kemwell Biopharma, a global contract development and manufacturing services provider, announced that it has appointed Siddharth J Advant, Ph.D. as President of its Biopharmaceutical Services. Anurag Bagaria, Chairman and Managing Director, said “Dr. Advant exemplifies Kemwell’s commitment to delivering high performance to its customers. He is a proven leader with over 20 years of experience in the biopharmaceutical industry. His extensive experience in CMC development and commercialization will help Kemwell grow its contract biotech business. As…

The New AdvantaPass™ Clean Room Wall Pass-Through System from AdvantaPure® Ensures Isolation for Fluid Transfer

AdvantaPure Permits Aseptic Transfer between Pharmaceutical Manufacturing Suites with Reduced Risk of Contamination Southampton, Pa. — AdvantaPure, the sanitary products division of NewAge® Industries, Inc., introduces AdvantaPass wall pass-through technology (patent pending) for transferring critical fluids during pharmaceutical and biopharmaceutical production. The system combines Single-Use tubing and isolation chamber assemblies with in-wall, permanent stainless steel components to eliminate cleaning validations associated with clean room protocols. AdvantaPass is the first system of its kind to offer complete isolation between manufacturing environments…

Kemwell Adds Lyophilization Capability

Kemwell ADDITION OF THE NEW FREEZE DRYING CAPABILITY SETS THE COMPANY ON A COURSE TO EXPAND BUSINESS FROM BOTH NEW AND EXISTING CUSTOMERS Bangalore, India – Kemwell Biopharma, a global contract development and manufacturing services provider, announced that it has installed and qualified its commercial scale lyophilizer. With this expansion, Kemwell has added GMP lyophilization capability to its sterile injectable offerings for biologics and pharmaceuticals. The lyophilizer has a shelf area of 7.5 sq.m. (~80 sq.ft) and is equipped with…